1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
6751A34D69D3C1A7B6525842E002A0308
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/maximizing-impact-medical-affairs-product-launch
18
19
203.91.106.44
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25BMR




Products & Services Medical Affairs Launch Optimization

Maximizing the Impact of Medical Affairs in Product Launch

ID: POP-311


Features:

36 Info Graphics

27 Data Graphics

510+ Metrics


Pages: 83


Published: 2019


Delivery Format: Shipped


 

License Options:
close

Single User: Authorizes use by the person who places the order or for whom the order was placed.

Sitewide: Authorizes use of the report for a geographic site. All people at site can view the report for a year and copies can be printed.

Corporate: Authorizes use for the entire company for a year and copies can be printed. No limitations for usage inside the company.




Buy Now

 

919-403-0251

  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • STUDY SNAPSHOT
  • KEY FINDINGS
  • VIEW TOC AND LIST OF EXHIBITS
In the past decade, Medical Affairs has significantly evolved to play a critical role in launch success. And in order to maximize its launch impact, Medical Affairs groups need to strategically deploy their resources and activities across key launch phases.

Best Practices, LLC undertook this benchmarking research to explore how Medical Affairs teams can deliver high-caliber, measurable value to their organization's new product launches.

This report delivers insights and benchmarks around Medical Affairs’ role, activities and timelines, cross-functional collaboration, strategy planning, staffing, budgeting, preparedness metrics, tools and technology for successful launch. This report also identifies the critical success factors and major pitfalls for Medical Affairs during launch.

Industries Profiled:
Pharmaceutical; Biotech; Biopharmaceutical; Chemical; Health Care; Diagnostic; Medical Device; Clinical Research; Laboratories


Companies Profiled:
AbbVie; AcelRx; Alcon Laboratories; Alkermes; Alnylam Pharmaceuticals; AstraZeneca; Bausch Health; Boehringer Ingelheim; Celgene; cipla; Clovis Oncology; Crescendo Bioscience; Curis; Daiichi Sankyo; Dermira; Eisai; EMD Serono; Exelixis ; Fidia; GE Healthcare; Gedeon Richter ; GRAIL; Grifols; Imbrium Therapeutics; Lundbeck; Medacta; Merck; Merck KGaA; Merz Pharma; Novartis; Orchard Therapeutics; Roche; Sandoz; Sanofi Genzyme; Sanofi; Santen; Servier; Shire; Taiho Oncology; Takeda Pharmaceuticals; Torrent Pharmaceuticals Ltd.; Vertex Pharmaceuticals; Vifor Pharma; Zydus Cadila

Study Snapshot

Best Practices, LLC engaged over 60 Medical Affairs leaders from 44 pharmaceutical, biotechnology and medical device companies in this research study through a benchmarking survey, interviews and a roundtable discussion.

Key topics covered in this report include:

  • Launch Strategy and Work Plan
  • Launch Timeline Overview
  • Launch Resourcing
  • Launch Enablers


Key Findings

Select key insights uncovered from this report are noted below. Detailed findings are available in the full report.

Medical Affairs can boost its launch performance by improving launch team collaboration and alignment (A), developing and sticking to a launch roadmap (B), and deploying effective launch enablers (C).

    A. Improve cross-functional collaboration (1) and alignment (2)

      1. Strengthen launch team effectiveness by setting clear roles and responsibilities for what each function, including Medical Affairs, must execute.
      2. Improve launch team alignment by deploying work timelines and increasing strategy transparency 24 months before the launch.

    B. Develop, deploy and adhere to a launch timeline

      1. Use launch roadmap to coordinate Medical Affairs activities with other functions, understand interdependencies, and prioritize activities and funding allocation.
      2. Start early to ensure sufficient funding and timing to deliver on activities.

    C. Develop and deploy launch enablers to ensure continuous improvement and efficient processes

      1. Develop and deploy strategic performance metrics along with more tactical metrics.
      2. Share best practices, work progress and critical information through a launch room (war room).
      3. Enable a feedback loop to leverage insights from the field to influence launch team’s activities.
Table of Contents

I.
Study Findings4
Executive Recommendations4
II.
Launch Strategy and Work Plan5
Medical Affairs Role and Activity Effectiveness14
Ensuring Cross-functional Alignment and Collaboration19
Adapting to Ongoing Changes in Medical Affairs Landscape23
Medical Affairs Leading vs. Supporting Launch Teams28
III.
Launch Timeline Overview34
IV.
Launch Resourcing44
V.
Launch Enablers49
Launch Preparedness Metrics49
Critical Success Factors and Major Pitfalls54
Technology59
VI.
Appendix63
Full Recommendations63
Participant Demographics67
Medical Affairs Role and Activity Effectiveness69
Launch Timeline76
Glossary81

    List of Charts & Exhibits

    I. Launch Strategy and Work Plan

    • Product launch: Medical Affairs role through 1990s to 2019 and beyond
    • Structure of the launch framework
    • Laying the groundwork for Medical Affairs launch excellence
    • Understanding the disease landscape
    • Setting medical strategic imperatives
    • Setting aspirational behaviors for key stakeholders
    • Planning stakeholder engagement
    • Planning resourcing and facilitating cross-functional collaboration

    I A . Medical Affairs Role and Activity Effectiveness

    • Growth in Medical Affairs’ role across multiple areas in recent years
    • Lead and support role of Medical Affairs
    • Medical Affairs’ effectiveness in launch activities

    I B . Ensuring Cross-functional Alignment and Collaboration

    • Collaboration with internal groups to ensure successful launch
    • Medical Affairs’ role in cross-functional teams
    • Tactics to improve cross-functional collaboration and work alignment

    I C . Adapting to Ongoing Changes in Medical Affairs Landscape

    • Medical Affairs’ focus area
    • Change in Medical Affairs’ launch role within the last 3 years – Research and data generation
    • Change in Medical Affairs’ launch role within the last 3 years – Data dissemination and communication
    • Change in Medical Affairs’ launch role within the last 3 years – Education and organizational support

    I D . Medical Affairs Leading vs. Supporting Launch Teams

    • Medical Affairs’ role in cross-functional launch teams
    • Leading/co-leading and supporting role played by Medical Affairs in different launch-related activities
    • Launch phase in which Medical Affairs groups lead/co-lead or support activities
    • Major pitfalls encountered by Medical Affairs during launch
    • Factors that facilitate Medical Affairs leadership and benefits of leading the launch team

    II. Launch Timeline Overview

    • Actual vs. ideal time to start launch activities

    II A . Launch Timeline Details

    • Launch timeline – Planning and budgeting Medical Affairs work
    • Launch timeline – Building Medical Affairs team and deploying progress trackers
    • Launch timeline – Organizational support and data generation
    • Launch timeline – Education and advisory boards
    • Launch timeline – Leading internal communication and building medical data
    • Launch timeline – Publications and medical congresses
    • Launch timeline – Engaging key external stakeholders

    III. Launch Resourcing

    • Medical Affairs staffing and investment breakdown before and post launch
    • Medical Affairs launch investment per medical FTE
    • Before and post launch budget allocation for key activities
    • Before and post launch staffing allocation for key activities

    IV. Launch Enablers

    IV A . Launch Preparedness Metrics

    • Existence of launch dashboard at benchmark companies and reported metrics usage by category type
    • Potential drug launch metrics (reported & Best Practices generated) – Strategy planning, project management, education and organizational support
    • Potential drug launch metrics (reported & Best Practices generated) – Communications and stakeholder engagement
    • Potential drug launch metrics (reported & Best Practices generated) – Stakeholder engagement

    IV B . Critical Success Factors and Major Pitfalls

    • Critical factors that drive successful launch for Medical Affairs
    • Six steps to a stronger launch
    • Major pitfalls for Medical Affairs during launch
    • Six pitfall areas at launch

    IV C . Technology

    • Communication tools used by Medical Affairs during launch and their relative popularity
    • CRM and collaboration tools used by Medical Affairs during launch and their relative popularity
    • Content management and materials building tools used by Medical Affairs during launch and their relative popularity

    V. Appendix

    • Complete executive insights and recommendations
    • Participant therapeutic areas
    • Medical Affairs’ role in launch planning and research activities
    • Medical Affairs’ role in education, data dissemination and organizational support activities
    • Effectiveness of launch research activities
    • Effectiveness of education activities
    • Effectiveness of communication and data dissemination activities
    • Effectiveness of Medical Affairs organizational support activities
    • Involvement of Medical Affairs in evidence generation and FBM related launch activities
    • Involvement of Medical Affairs in medical information and regulatory related launch activities
    • Involvement of Medical Affairs in HEOR and medical/scientific communication related launch activities
    • Involvement of Medical Affairs in independent medical education and external engagement/collaboration related launch activities
    • Glossary